News

FDA includes follow-on versions in its new liposome guideline

Published on 2016/10/19

On 29 October 2015, the US Food and Drug Administration (FDA) issued a new draft guidance document for non-biological complex drugs (NBCDs). The new draft guidance on liposome drug products replaces d...

1 views

Read more →

Measures to increase generics use in Greece

Published on 2016/10/17

Austerity has forced Greece to introduce a number of measures to reduce the amount it spends on healthcare. But how have measures aimed at increasing generics use in the country been perceived by ...

6 views

Read more →

BSG guidance recommends switching to biosimilar infliximab

Published on 2016/10/14

The British Society of Gastroenterology (BSG) released new guidance in February 2016 recommending that stable patients be switched to biosimilar infliximab (CT-P13). Biosimilar infliximab...

16 views

Read more →

Consumer choice between generic and brand-name medicines in a small generics market

Published on 2016/10/12

Background Generics offer an opportunity to governments to contain pharmaceutical expenditures, as they are generally 10‒80% lower in price than the originator brand-name medicines. Belgium has...

1 views

Read more →

Differences between biosimilars and reference products

Published on 2016/10/10

A review of glycosylated biosimilars approved in the European Union (EU) and Japan has highlighted structural variances between biosimilars and their reference products [1]. Biosimilars a...

8 views

Read more →

Impact of generics on European budgets

Published on 2016/10/07

A report by the Germany-based Institute for Healthcare and Social Research (IGES) released on 16 November 2015 found that generics could contribute to reducing healthcare budgets for European coun...

2 views

Read more →

Pharmacists’ attitudes towards domestic generics in Afghanistan

Published on 2016/10/05

The aim of the study by Hassali et al. was to survey community pharmacists regarding their attitudes about the quality and price of locally manufactured medicines [1]. A cross-sectional d...

3 views

Read more →

Prescribing similar biotherapeutic products in Latin America

Published on 2016/10/03

Prescribing practices vary across different countries in Latin America and reveal gaps in understanding and in the use of distinguishable names for biologicals [1]. A 15-minute web-based ...

3 views

Read more →

Paediatric use of low-cost generic programs in the US

Published on 2016/09/30

Low-cost generic drug programs (LCGPs) in the US increase the affordability of prescription medication that can treat many common paediatric conditions. LCGPs are a loss-leader pricing strategy us...

0 views

Read more →

Generics market share in Europe

Published on 2016/09/28

Generics make a major contribution to the European drug supply, according to a report by the by Germany-based Institute for Healthcare and Social Research (IGES). In most European countri...

5 views

Read more →

Physicians’ and pharmacists’ perspectives on generics use

Published on 2016/09/26

The review study of Toverud et al. shows that both physicians and pharmacists have acknowledged strategies for generics use as an attempt to curtail increasing drug expenditures [1]. However, in N...

4 views

Read more →

Barriers to biologicals competition

Published on 2016/09/23

As finding breakthrough small-molecule drugs becomes more difficult, drug companies are increasingly turning to ‘large molecule’ biologicals. Although biologicals represent many of the most pr...

1 views

Read more →